These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


259 related items for PubMed ID: 24048413

  • 1. Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis.
    Westbury SK, Duval C, Philippou H, Brown R, Lee KR, Murden SL, Phillips E, Reilly-Stitt C, Whalley D, Ariëns RA, Mumford AD.
    Thromb Haemost; 2013 Dec; 110(6):1135-44. PubMed ID: 24048413
    [Abstract] [Full Text] [Related]

  • 2. The fibrinogen Aalpha R16C mutation results in fibrinolytic resistance.
    Flood VH, Al-Mondhiry HA, Farrell DH.
    Br J Haematol; 2006 Jul; 134(2):220-6. PubMed ID: 16846481
    [Abstract] [Full Text] [Related]

  • 3. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
    Marchi R, Lundberg U, Grimbergen J, Koopman J, Torres A, de Bosch NB, Haverkate F, Arocha Piñango CL.
    Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699
    [Abstract] [Full Text] [Related]

  • 4. Novel Aalpha chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization.
    Homer VM, Mullin JL, Brennan SO, Barr A, George PM.
    J Thromb Haemost; 2003 Jun; 1(6):1245-50. PubMed ID: 12871326
    [Abstract] [Full Text] [Related]

  • 5. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
    Terasawa F, Kani S, Hongo M, Okumura N.
    Thromb Res; 2006 Jun; 118(5):651-61. PubMed ID: 16412498
    [Abstract] [Full Text] [Related]

  • 6. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
    Kotlín R, Reicheltová Z, Malý M, Suttnar J, Sobotková A, Salaj P, Hirmerová J, Riedel T, Dyr JE.
    Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467
    [Abstract] [Full Text] [Related]

  • 7. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
    Kamijyo Y, Hirota-Kawadobora M, Yamauchi K, Terasawa F, Honda T, Ikeya M, Okumura N.
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
    [Abstract] [Full Text] [Related]

  • 8. A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function.
    Riedelová-Reicheltová Z, Kotlín R, Suttnar J, Geierová V, Riedel T, Májek P, Dyr JE.
    Thromb Haemost; 2014 Jan; 111(1):79-87. PubMed ID: 24108601
    [Abstract] [Full Text] [Related]

  • 9. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K, Terasawa F, Okumura N.
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [Abstract] [Full Text] [Related]

  • 10. Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization.
    Amri Y, Jouini H, Becheur M, Dabboubi R, Mahjoub B, Messaoud T, Sfar MT, Casini A, de Moerloose P, Toumi NEH.
    Haemophilia; 2017 Jul; 23(4):e340-e347. PubMed ID: 28594476
    [Abstract] [Full Text] [Related]

  • 11. Dusart Syndrome in a Scandinavian family characterized by arterial and venous thrombosis at young age.
    Ramanathan R, Gram J, Feddersen S, Nybo M, Larsen A, Sidelmann JJ.
    Scand J Clin Lab Invest; 2013 Oct; 73(7):585-90. PubMed ID: 24000886
    [Abstract] [Full Text] [Related]

  • 12. Functional characterization of fibrinogen Bicêtre II: a gamma 308 Asn-->Lys mutation located near the fibrin D:D interaction sites.
    Marchi RC, Carvajal Z, Boyer-Neumann C, Anglés-Cano E, Weisel JW.
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):193-201. PubMed ID: 16575257
    [Abstract] [Full Text] [Related]

  • 13. Streptococcus gordonii FSS2 Challisin affects fibrin clot formation by digestion of the αC region and cleavage of the N -terminal region of the Bβ chains of fibrinogen.
    Harty DW, Farahani RM, Simonian MR, Hunter L, Hunter N.
    Thromb Haemost; 2012 Aug; 108(2):236-46. PubMed ID: 22552295
    [Abstract] [Full Text] [Related]

  • 14. Fibrinogen αC-subregions critically contribute blood clot fibre growth, mechanical stability, and resistance to fibrinolysis.
    McPherson HR, Duval C, Baker SR, Hindle MS, Cheah LT, Asquith NL, Domingues MM, Ridger VC, Connell SD, Naseem KM, Philippou H, Ajjan RA, Ariëns RA.
    Elife; 2021 Oct 11; 10():. PubMed ID: 34633287
    [Abstract] [Full Text] [Related]

  • 15. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.
    Undas A, Zdziarska J, Iwaniec T, Stepien E, Skotnicki AB, de Moerloose P, Neerman-Arbez M.
    Thromb Haemost; 2009 May 11; 101(5):975-6. PubMed ID: 19404553
    [No Abstract] [Full Text] [Related]

  • 16. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
    Greenhalgh KA, Strachan MW, Alzahrani S, Baxter PD, Standeven KF, Storey RF, Ariens RA, Grant PJ, Price JF, Ajjan RA.
    Thromb Haemost; 2017 Jan 26; 117(2):295-302. PubMed ID: 27929198
    [Abstract] [Full Text] [Related]

  • 17. Functional characterisation of plasma fibrin clots in Polish carriers of fibrinogen gammaArg275His mutation (fibrinogen Zabrze).
    Undas A, Pastuszczak M, Iwaniec T, Kapelak K, Neerman-Arbez M.
    Thromb Haemost; 2010 Aug 26; 104(2):415-7. PubMed ID: 20508898
    [No Abstract] [Full Text] [Related]

  • 18. Heritability of clot formation.
    Standeven KF, Uitte de Willige S, Carter AM, Grant PJ.
    Semin Thromb Hemost; 2009 Jul 26; 35(5):458-67. PubMed ID: 19739036
    [Abstract] [Full Text] [Related]

  • 19. Structure of fibrin network of two abnormal fibrinogens with mutations in the αC domain on the human dermal microvascular endothelial cells 1.
    Marchi R, Rojas H, Castillo O, Kanzler D.
    Blood Coagul Fibrinolysis; 2011 Dec 26; 22(8):706-11. PubMed ID: 21986467
    [Abstract] [Full Text] [Related]

  • 20. Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA).
    Marchi R, Carvajal Z, Meyer M, Soria J, Ruiz-Saez A, Arocha-Piñango CL, Weisel JW.
    Thromb Res; 2006 Dec 26; 118(5):637-50. PubMed ID: 16406498
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.